The Proof-of-concept demonstrator (POD) call for expressions of interest aims to identify projects in the field of biotherapies, requiring to de-risk innovation with the support of an industrial integrator at Paris Region.

The objective of a POD project is to provide access to state-of-the-art integrator expertise and technologies necessary to accelerate and facilitate the early stages of clinical trials for members of DIM BioConvS.

Through the France 2030 program of the french government, Inserm coordinates the integrator in biotherapy/bioproduction program (IBB program). Within this program, these 3 academic platforms of Region Ile de France ( IVETH, Magenta (ART-TG), Meary) provide expertise in the bioproduction of biotherapies, enabling them to:

• Facilitate the development, transfer, and access to skills and tools for project leaders developing bioproduction technologies and biotherapies.
• Provide access to bioproduction equipment and create a conducive research environment.
• Participate in the development of start-ups.